148 related articles for article (PubMed ID: 5061528)
21. Various vagaries of vasoconstriction.
Burdick KH
Arch Dermatol; 1974 Aug; 110(2):238-42. PubMed ID: 4855376
[No Abstract] [Full Text] [Related]
22. Paper-patch test for evaluating vasoconstrictive activity of corticosteroids.
Falconi G; Rossi GL
Arch Dermatol; 1972 Jun; 105(6):856-8. PubMed ID: 5030235
[No Abstract] [Full Text] [Related]
23. [The significance of acanthosis for external therapy].
Berres HH
Med Welt; 1968 Sep; 37():1976-8. PubMed ID: 5712119
[No Abstract] [Full Text] [Related]
24. Recent progress in the formulation of vehicles for topical applications.
Hadgraft JW
Br J Dermatol; 1972 Oct; 87(4):386-9. PubMed ID: 4562170
[No Abstract] [Full Text] [Related]
25. Pharmacological studies with a new antimicrobial cream.
Schoog M; Weih H; Dimmling T; Schimpf A; Winkler E
Arzneimittelforschung; 1972 Jun; 22(6):1022-7. PubMed ID: 5068349
[No Abstract] [Full Text] [Related]
26. Corticosteroid bioavailability assays. Correlation with a clinical study.
Burdick KH
Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):19-23. PubMed ID: 5291630
[No Abstract] [Full Text] [Related]
27. [Contact allergies to polyethylene glycols].
Braun W
Z Haut Geschlechtskr; 1969 Jun; 44(11):385-9. PubMed ID: 5360183
[No Abstract] [Full Text] [Related]
28. [Absorption of corticoid ointments].
Winkler K
Ann Dermatol Syphiligr (Paris); 1966; 93(3):265-70. PubMed ID: 5963643
[No Abstract] [Full Text] [Related]
29. Topical adrenal steroids and patch tests.
Fisher AA
Arch Dermatol; 1983 Dec; 119(12):956. PubMed ID: 6651311
[No Abstract] [Full Text] [Related]
30. [The toxicologic characteristics of a new SAKAP-based benzyl benzoate ointment].
Sokolova TV; Alchangian LV; Alekseev KV; Aĭvazian AA; Stepanov IuV
Vestn Dermatol Venerol; 1989; (9):21-6. PubMed ID: 2609759
[TBL] [Abstract][Full Text] [Related]
31. [Effect of admixture of commercially available corticosteroid ointments and/or creams on vasoconstrictor activity].
Ohtani M; Yamada N; Takayama K; Kotaki H; Etoh T; Kariya S; Uchino K; Iga T
Yakugaku Zasshi; 2002 Jan; 122(1):107-12. PubMed ID: 11828745
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of bioavailability by lowering of fat content in topical formulations.
Wirén K; Frithiof H; Sjöqvist C; Lodén M
Br J Dermatol; 2009 Mar; 160(3):552-6. PubMed ID: 19120336
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacokinetics and efficacy of skin medications].
Stüttgen G
Hautarzt; 1981 Apr; 32(4):199-207. PubMed ID: 6112211
[TBL] [Abstract][Full Text] [Related]
34. Vehicle effects on in vitro skin permeation of thiocolchicoside.
Bonina F; Puglia C; Trombetta D; Dragani MC; Gentile MM; Clavenna G
Pharmazie; 2002 Nov; 57(11):750-2. PubMed ID: 12611278
[TBL] [Abstract][Full Text] [Related]
35. [The effect of urea in a topical corticoid preparation on vasoconstriction].
Früh H
Z Hautkr; 1983 Aug; 58(16):1203-5. PubMed ID: 6624181
[TBL] [Abstract][Full Text] [Related]
36. [Problems in allergological studies of a patient with a probable Flammazine cream allergy].
van der Horst JC; van Ketel WG
Ned Tijdschr Geneeskd; 1982 May; 126(19):841-3. PubMed ID: 6212771
[No Abstract] [Full Text] [Related]
37. Are ointments better than other vehicles for corticosteroid treatment of psoriasis?
Zivkovich AH; Feldman SR
J Drugs Dermatol; 2009 Jun; 8(6):570-2. PubMed ID: 19537382
[TBL] [Abstract][Full Text] [Related]
38. [The pharmacokinetics of external skin preparations].
Wohlrab W; Wozniak KD; Taube KM
Pharmazie; 1984 Sep; 39(9):614-5. PubMed ID: 6504996
[No Abstract] [Full Text] [Related]
39. [Practical value and evaluation criteria of external corticoid drugs].
Weirich EG
Wien Med Wochenschr; 1966 Aug; 116(34):681-8 concl. PubMed ID: 5987614
[No Abstract] [Full Text] [Related]
40. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. II. Influence of solvents (author's transl)].
Altmeyer P; Zaun H
Arch Dermatol Forsch; 1974 Feb; 248(4):387-90. PubMed ID: 4834644
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
